Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations
| Distributed by / for | ULTRAtab Laboratories, Inc. |
| NDC | 62969-242-00 |
| Full product label | HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62969-242-00 |
| Recalling firm | ULTRAtab Laboratories, Inc. |
| Distribution | Bulk product was distributed to 3 distributors who may have distributed finished product. |
| Quantity | 50,585,623 tablets |
| Recall initiated | 2022-01-26 |
| Report date | 2022-02-16 |
| Recall completed | 2025-01-07 |
| Recall number | D-0538-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Highland NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗